1. Home
  2. STXS vs GECC Comparison

STXS vs GECC Comparison

Compare STXS & GECC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STXS
  • GECC
  • Stock Information
  • Founded
  • STXS 1990
  • GECC 2016
  • Country
  • STXS United States
  • GECC United States
  • Employees
  • STXS N/A
  • GECC N/A
  • Industry
  • STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • GECC Finance: Consumer Services
  • Sector
  • STXS Health Care
  • GECC Finance
  • Exchange
  • STXS Nasdaq
  • GECC Nasdaq
  • Market Cap
  • STXS 151.3M
  • GECC 122.4M
  • IPO Year
  • STXS 2004
  • GECC N/A
  • Fundamental
  • Price
  • STXS $2.17
  • GECC $10.52
  • Analyst Decision
  • STXS
  • GECC
  • Analyst Count
  • STXS 0
  • GECC 0
  • Target Price
  • STXS N/A
  • GECC N/A
  • AVG Volume (30 Days)
  • STXS 270.0K
  • GECC 20.1K
  • Earning Date
  • STXS 08-11-2025
  • GECC 07-31-2025
  • Dividend Yield
  • STXS N/A
  • GECC 14.21%
  • EPS Growth
  • STXS N/A
  • GECC N/A
  • EPS
  • STXS N/A
  • GECC 0.42
  • Revenue
  • STXS $27,510,000.00
  • GECC $42,909,000.00
  • Revenue This Year
  • STXS $25.90
  • GECC $32.54
  • Revenue Next Year
  • STXS $60.57
  • GECC N/A
  • P/E Ratio
  • STXS N/A
  • GECC $25.48
  • Revenue Growth
  • STXS 1.50
  • GECC 18.13
  • 52 Week Low
  • STXS $1.54
  • GECC $8.87
  • 52 Week High
  • STXS $2.72
  • GECC $11.39
  • Technical
  • Relative Strength Index (RSI)
  • STXS 52.27
  • GECC 47.14
  • Support Level
  • STXS $2.00
  • GECC $10.28
  • Resistance Level
  • STXS $2.36
  • GECC $10.60
  • Average True Range (ATR)
  • STXS 0.11
  • GECC 0.25
  • MACD
  • STXS -0.01
  • GECC -0.05
  • Stochastic Oscillator
  • STXS 50.00
  • GECC 25.53

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

About GECC Great Elm Capital Corp.

Great Elm Capital Corp is an externally managed, non-diversified closed-end management investment company. It generate both income and capital appreciation through debt and income-generating equity investments, including investments in finance businesses.

Share on Social Networks: